Continuo de la atención de personas que viven con VIH y brechas para el logro de las metas 90-90-90 en Perú

García-Fernández, Lisset; Novoa, Rommy H.; Huamán, Byelca; Benites, Carlos

doi:10.17843/rpmesp.2018.353.3853

Cited by 19 publications

(23 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…In Peru, among the estimated 72,000 PWH, 64% had been diagnosed, 46% were on ART, and 36% had achieved viral suppression. 36 However, the challenges of maintaining or improving these figures could worsen during the COVID-19 pandemic due to the reallocation of health resources previously directed toward funding HIV care toward the inpatient care of patients with COVID-19. HIV medications are supplied and provided for free to all PWH by the Peruvian Ministry of Health, now with a three-month supply being provided to patients to help prevent shortages with ART home delivery in many regions since the beginning of the pandemic.…”

Section: Challenges To Continuity Of Hiv Care During the Pandemicmentioning

confidence: 99%

Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

Diaz

Cabrera

Gil-Zacarias

et al. 2021

Preprint

View full text Add to dashboard Cite

COVID-19 has had an unprecedented worldwide impact, and Peru has had one of the highest COVID-19 case rates despite implementation of an early strict nationwide quarantine. Repercussions on Peru healthcare system may impact vulnerable populations, particularly people with HIV (PWH). We explored the knowledge of COVID-19 and the socioeconomic and health impact of the pandemic among middle-aged and older PWH. A cross-sectional telephone survey was administered to 156 PWH age >=40 years receiving care in one of two large HIV clinics in Lima, Peru. The majority of PWH (age 52+/-7.7 years, 41% female, 65% completed secondary school or less) were knowledgeable regarding COVID-19 symptoms and prevention methods. Nearly half of those employed prior to the pandemic reported job loss. Female sex (unadjusted prevalence ratio [PR] 1.85 [95%CI 1.27-2.69]), low educational level (PR 1.62 [1.06-2.48]) and informal work (PR 1.58 [1.06-2.36]) were risk factors for unemployment but not in adjusted models. Increased anxiety was reported in 64% and stress in 77%. COVID-19 has had a substantial socioeconomic and mental health impact on PWH living in Lima, Peru, particularly those with lower educational levels and informal workers. Efforts are needed to ensure continued medical care and socioeconomic support of PWH in Peru.

show abstract

Section: Challenges To Continuity Of Hiv Care During the Pandemicmentioning

confidence: 99%

Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

Diaz

Cabrera

Gil-Zacarias

et al. 2021

Preprint

View full text Add to dashboard Cite

show abstract

“…Overall, Peru has achieved moderate progress in achieving the 90-90-90 targets for 2020 [31] as an estimated 60% (43,000) of PLHIV know their status, 60% (43,000) are receiving ART, and 60% (24,000) in treatment are virally suppressed [5, 32]. Importantly, target measurement is largely based on estimates as there is not a national monitoring system [33].…”

Section: Introductionmentioning

confidence: 99%

Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study

et al. 2019

View full text Add to dashboard Cite

Background There are approximately 72,000 people living with HIV/AIDS (PLHIV) in Peru. Non-adherence to antiretroviral therapy (ART) is the most important factor for therapeutic failure and the development of resistance. Peru has achieved moderate progress in meeting the 90-90-90 targets, but only 60% of PLHIV receiving ART are virally suppressed. The purpose of this study was to understand ART adherence in the Peruvian context, including developing sociodemographic and clinical profiles, evaluating the clinical management strategies, and analyzing the relationships between the variables and adherence of PLHIV managed at a regional HIV clinic in Lambayeque Province (Northern Peru). Methods This was a cross-sectional study with 180 PLHIV adults, non-randomly but consecutively selected with self-reported ART compliance (78.2% of the eligible population). The PLHIV profile (PLHIV-Pro) and the Simplified Medication Adherence Questionnaire (SMAQ) were used to collect sociodemographic information, clinical variables, and data specific to ART adherence. Descriptive analysis of sociodemographic and clinical characteristics was performed. Bivariate analysis was performed with the Mann–Whitney test, Chi square test, and Yates correction. Results The 180 PLHIV sample included 78.9% men, 49.4% heterosexual, 45% with a detectable HIV-1 viral load less than 40 copies/ml, 58.3% not consistently adherent, and only 26.1% receiving Tenofovir + Lamivudine + Efavirenz. Risk factors significant for non-adherence included concurrent tuberculosis, discomfort with the ART regime, and previous pauses in ART. Multivariate analysis of nested models indicated having children is a protector factor for adherence. Conclusions Self-reported adherence appeared to be low and the use of first-line therapy is not being prescribed homogeneously. Factors associated with nonadherence are both medical and behavioral, such as having tuberculosis, pausing ART, or experiencing discomfort with ART. The Peruvian government needs to update national technical standards, monitor medication availability, and provide education to health care professionals in alignment with evidence-based guidelines and international recommendations. Instruments to measure adherence need to be developed and evaluated for use in Latin America.

show abstract

“…En el 2014, el Programa Conjunto de las Naciones Unidas sobre el VIH/SIDA (ONUSIDA) lanzó las «metas 90-90-90»(8) para el 2020, es decir, que el 90% de todas las PVV conozcan su estado serológico, que el 90% de las PVV diagnosticadas reciban TAR, y que 90% de las que reciben tratamiento logren supresión viral(8) , para eliminar la transmisión en el 2030.En el mundo se han logrado avances importantes para las «metas 90-90-90»(8) . En el Perú, en el 2014, de las 72 000 PVV estimadas, el 64% había sido diagnosticado, el 46% estaban en TAR y el 36% había logrado la supresión viral(9) . Para el 2018, una nueva medición reportó mejores cifras: el 78% de las PVV conocían su diagnóstico, el 76% estaban en TAR y el 65% habían alcanzado la supresión viral(10) .…”

unclassified

Los desafíos en la continuidad de atención de personas viviendo con VIH en el Perú durante la pandemia de la COVID-19

Paredes

Navarro

Cabrera

et al. 2021

Rev Peru Med Exp Salud Publica

View full text Add to dashboard Cite

La pandemia por la COVID-19 y las medidas restrictivas de distanciamiento social pueden interactuar con la epidemia de VIH de múltiples formas. Existen aproximadamente 87 000 personas viviendo con VIH (PVV) en el Perú quienes están en riesgo de contraer la COVID-19; 67 000 de ellas que reciben tratamiento antirretroviral (TAR) podrían tener limitaciones en el acceso a sus medicamentos, comprometiendo su adherencia y su salud. Además, el efecto que podría tener la pandemia en la salud mental de PVV en Perú aún no está esclarecido. Este artículo tiene como finalidad describir las implicancias clínicas de la coinfección VIH/SARS-CoV-2; discutir los desafíos en la continuidad de atención de las PVV en el Perú durante la crisis sanitaria por la COVID-19; y comentar las posibles implicancias de las medidas restrictivas sobre la salud mental de las PVV.

show abstract

Continuo de la atención de personas que viven con VIH y brechas para el logro de las metas 90-90-90 en Perú

Cited by 19 publications

References 0 publications

Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

Knowledge and Impact of COVID-19 on Middle-Aged and Older People living with HIV in Lima, Peru

Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study

Los desafíos en la continuidad de atención de personas viviendo con VIH en el Perú durante la pandemia de la COVID-19

Contact Info

Product

Resources

About